Home/MediMabBio/Jennifer Yuhoi Kang, D.Phil.

JY

Jennifer Yuhoi Kang, D.Phil.

Founder & Co-CEO

Therapeutic Areas

Oncology Autoimmune Diseases

MediMabBio Pipeline

Drug	Indication	Phase
aTIGIT-IL15 Fusion Antibody	Oncology	Pre-clinical

Leadership Team at MediMabBio

Hongseok Jo, Ph.D.

Founder & Co-CEO

Ji-Eun Lee, Ph.D.

CEO of MediMab Biotherapeutics

Eunhyuk Chang, D.Phil.

CSO (Chief Strategy Officer)

View full MediMabBio profile